The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
Over 7,300 tonnes of UAE humanitarian aid arrives in Gaza
UAE President gifts H.H. Sheikh Mohammed photo album celebrating shared journey
UAE condemns terrorist bombing targeting Pakistani police forces
UAE welcomes US designation of Muslim Brotherhood branches as 'terrorists'
